Find the latest Nevro Corp. (NVRO) stock quote, history, news and other vital information to help you with your stock trading and investing.

3 days ago · Globus Medical (GMED, Financials) agreed to acquire Nevro Corp. (NVRO, Financials) in an all-cash transaction valued at approximately $250 million. Warning!

Get the latest Nevro Corp. (NVRO) stock news and headlines to help you in your trading and investing decisions.

NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 preliminary results amid a weak SCS market.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Nov 8, 2024 · Nevro Corp (NYSE:NVRO) is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is $93.07 million, and the earnings are expected to come in at -$0.76 per ...

NVRO expects fourth-quarter 2024 U.S. revenues to be in the range of $91 million-$92 million, representing a decrease of 9% to 10% compared with the fourth quarter of 2023.

In this article, we are going to take a look at where Nevro Corp. (NYSE:NVRO) stands against Engaged Capital's other top holdings.

See the company profile for Nevro Corp. (NVRO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Nevro NVRO recently announced that the FDA has given 501(k) clearance for its sacroiliac (SI) joint fusion device, Nevro1. This innovative system, developed by Vyrsa Technologies, offers a unique ...